KDELR2 expression was enhanced in various tumour tissues, including breast cancer, head and neck cancer, kidney cancer, liver cancer, lung cancer, colon cancer, bladder cancer and glioblastoma (Figure 1a). Here, KDELR2 is linked to kidney cancer.